Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
about
Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigenA chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.Development of a Sterne-Based Complement Fixation Test to Monitor the Humoral Response Induced by Anthrax VaccinesGlycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives.Host immunity to Bacillus anthracis lethal factor and other immunogens: implications for vaccine design.Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): anthrax
P2860
Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Protective activity and immuno ...... x vaccines for veterinary use.
@ast
Protective activity and immuno ...... x vaccines for veterinary use.
@en
type
label
Protective activity and immuno ...... x vaccines for veterinary use.
@ast
Protective activity and immuno ...... x vaccines for veterinary use.
@en
prefLabel
Protective activity and immuno ...... x vaccines for veterinary use.
@ast
Protective activity and immuno ...... x vaccines for veterinary use.
@en
P2093
P50
P1433
P1476
Protective activity and immuno ...... x vaccines for veterinary use.
@en
P2093
P304
P356
10.1016/J.VACCINE.2008.08.026
P407
P577
2008-09-04T00:00:00Z